Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment

Clinical trial NCT05999968 · TERMINATED

Trial details

NCT number: NCT05999968
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2024-01-12
Primary completion: 2024-02-23
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.